about
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer.18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer PatientsOpen Source Infrastructure for Health Care Data Integration and Machine Learning Analyses
P50
description
researcher ORCID ID = 0000-0003-1650-0918
@en
wetenschapper
@nl
name
Pia Roering
@ast
Pia Roering
@en
Pia Roering
@es
Pia Roering
@nl
type
label
Pia Roering
@ast
Pia Roering
@en
Pia Roering
@es
Pia Roering
@nl
prefLabel
Pia Roering
@ast
Pia Roering
@en
Pia Roering
@es
Pia Roering
@nl
P106
P1153
57021957600
P31
P496
0000-0003-1650-0918